Sonoma Pharmaceuticals Inc. Common Stock (SNOA)

About SNOA

Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peel…

Sector

Health Care

Industry

Medical/Dental Instruments

Employees

10

Website

sonomapharma.com

Fundamentals

1-day range

$1.23$1.45

Market cap

$5.99M

P/E (trailing)

—

P/E (forward)

-2.57

EPS (trailing)

$-1.22

Dividend yield

—

Beta

1.29

Avg. volume

159.6K

Dividend pay date

June 20, 2019

Sonoma Pharmaceuticals Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• SNOA

  Sonoma Pharmaceuticals Inc. Common Stock

  $1.31

  ▼ 1.50%
  Market cap $5.99MP/E —
  $0.85$6.92
• NVNO

  enVVeno Medical Corporation Common Stock

  $10.67

  ▼ 5.12%
  Market cap $6.93MP/E —
  $8.67$36.05
• XAIR

  Beyond Air Inc. Common Stock

  $4.58

  ▼ 19.65%
  Market cap $4.93MP/E —
  $4.25$95.6
• INBS

  Intelligent Bio Solutions Inc. Common Stock

  $2.36

  ▲ 3.96%
  Market cap $4.76MP/E —
  $1.52$24.9
• VVOS

  Vivos Therapeutics Inc. Common Stock

  $0.2245

  ▼ 12.98%
  Market cap $4.47MP/E —
  $0.24$4.93
• IVF

  INVO Fertility Inc. Common Stock

  $1.01

  ▼ 2.43%
  Market cap $2.39MP/E —
  $0.9001$84.4
• CODX

  Co-Diagnostics Inc. Common Stock

  $1.2

  ▼ 4.76%
  Market cap $9.91MP/E —
  $0.9396$46.5

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Sonoma Pharmaceuticals Q1 EPS $(0.09) Up From $(0.76) YoY, Sales $6.406M Up From $4.015M YoY
  Benzinga · 8/6/2026
• Sonoma Pharmaceuticals Turns EBITDA Positive for First Time with Record Quarterly Revenue
  Benzinga · 8/6/2026

• Weigerstorfer Philippe · July 9, 2026 · Grant

  10.0K
• Trombly Amy Moss · July 9, 2026 · Grant

  10.0K
• Jacoby Vanessa · July 9, 2026 · Grant

  10.0K
• DVONCH JEROME J · July 9, 2026 · Grant

  10.0K
• Dal Poggetto John · July 9, 2026 · Grant

  7.5K
• MCLAUGHLIN JOHN · July 9, 2026 · Grant

  10.0K

Institutional Ownership

March 31, 2026

Total shares held

67.2K

Total value held

$143.2K

Institutional holders

15